Brind.

TD Cowen analysts questioned Kemper regarding its policy growth, with Mitchell Rubin seeking clarification from the Kemper CEO on August 13, 2025.

1 report, 1 independent Updated Aug 13

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

TD Cowen KemperMitchell Rubin

Keep exploring

The entities involved

TD Cowen
American investment bank
- Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
- TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36
Kemper
company in the Czech Republic

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 13StockStoryKemper’s Q2 Earnings Call: Our Top 5 Analyst Questions Kemper’s second-quarter results fell short of Wall Street expectations, prompting a significant negative reaction from the market. Management at